Loading clinical trials...
Loading clinical trials...
A First-in-Human, Phase I/II PET Imaging Study of 64Cu-GRIP B, a Radiotracer Targeting Granzyme B, in Patients With Advanced Malignancies
Conditions
Interventions
Copper-64 labeled Granzyme B (64Cu-GRIP B)
Positron Emission Tomography (PET)
Locations
1
United States
University of California, San Francisco
San Francisco, California, United States
Start Date
May 25, 2023
Primary Completion Date
December 31, 2026
Completion Date
January 31, 2027
Last Updated
March 17, 2026
NCT06926283
NCT06844383
NCT07177937
NCT06594926
NCT06487507
NCT07004582
Lead Sponsor
Rahul Aggarwal
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions